| Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Outline of Final Research Achievements |
Mitochondrial disorders, an intractable genetic disease, is the disorders who have not produce enough ATP generation. Using rho zero cellular model, we have identified GDF15, which is the most useful and reliable mitochondrial biomarker for diagnosis and monitor the clinical progression in mitochondrial disorders. We have been developing the testing device of GDF15 and doing the clinical trial for application for diagnostic device in Japan.
|
